Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study | Circulation | 2007 | 596 |
Proinflammatory profile within the grossly normal aged human aortic wall | Hypertension | 2007 | 204 |
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model | Endocrine-Related Cancer | 2007 | 141 |
Standardization of HER2 testing: results of an international proficiency-testing ring study | Modern Pathology | 2007 | 109 |
Molecular response to aromatase inhibitor treatment in primary breast cancer | Breast Cancer Research | 2007 | 97 |
Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer | Breast Cancer Research and Treatment | 2007 | 94 |
Mechanisms of disease: angiogenesis and the management of breast cancer | Nature Clinical Practice Oncology | 2007 | 93 |
Introduction to sessions on Personalising treatment | Breast Cancer Research | 2007 | 78 |
International Web-based consultation on priorities for translational breast cancer research | Breast Cancer Research | 2007 | 76 |
Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways | Experimental Cell Research | 2007 | 66 |
Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women - exercise and premenopausal hormones | Cancer Causes and Control | 2007 | 64 |
Usual physical activity and endogenous sex hormones in postmenopausal women: the European prospective investigation into cancer-norfolk population study | Cancer Epidemiology Biomarkers and Prevention | 2007 | 62 |
Clinical strategies for rationale combinations of aromatase inhibitors with novel therapies for breast cancer | Journal of Steroid Biochemistry and Molecular Biology | 2007 | 44 |
Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels | Journal of Steroid Biochemistry and Molecular Biology | 2007 | 41 |
The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression in vitro and in vivo | Molecular Cancer Therapeutics | 2007 | 36 |
Predictors of response to aromatase inhibitors | Journal of Steroid Biochemistry and Molecular Biology | 2007 | 28 |
Aromatase inhibitors and male breast cancer | Clinical and Translational Oncology | 2007 | 26 |
Separation of Aloins A and B from Aloe Vera Exudates by High Speed Countercurrent Chromatography | Journal of Liquid Chromatography and Related Technologies | 2007 | 17 |
Effect of tibolone on breast cancer cell proliferation in postmenopausal ER+ patients: results from STEM trial | Clinical Cancer Research | 2007 | 17 |
Short-term presurgical treatment for all? | Breast Cancer Research | 2007 | 4 |